Skip to main content

Who Bought Those SunPharma Shares?

Deepak Shenoy1 min read
Quick Facts
What is "Who Bought Those SunPharma Shares?" about?
What category is this article in?
Stocks
Who wrote this article?
Deepak Shenoy, Capitalmind's research team.
When was this article published?
Published 22 April 2015.
How long does this article take to read?
1 min read
What topics does this article cover?
Pharmaceuticals
What does the "Rs. 1,915 cr." section say?
[/fusiontext][/onethird][onethird last="no" spacing="yes" backgroundcolor="" backgroundimage="" backgroundrepeat="no-repeat" backgroundposition="left top" bordersize="0px" bordercolor="" borderstyle="" padding="" class="" id=""][title size="2" contentalign="left" styletype="single" sepcolor="" class="" id=""]Singapore Govt.[/title][fusiontext]
What does the "Rs. 1,197 cr." section say?
[/fusiontext][/onethird][onethird last="yes" spacing="yes" backgroundcolor="" backgroundimage="" backgroundrepeat="no-repeat" backgroundposition="left top" bordersize="0px" bordercolor="" borderstyle="" padding="" class="" id=""][title size="2" contentalign="left" styletype="single" sepcolor="" class="" id=""]Goldman Sachs[/title][fusiontext]
What does the "Rs. 4,864 cr." section say?
[/fusiontext][/onethird][fusiontext]

[fusion_text] After that insane 20,000 cr. volume in Sun Pharma yesterday as Daiichi sold a whopping Rs. 20,000 cr. worth shares, who really bought them?

Turns out the buyers weren’t named Dilip Shanghvi (the promoter of Sun Pharma). While we don’t know the identity of all other buyers, we do know from NSE’s Bulk Deals reporting that three big investors bought into Daiichi’s selling. Here they are: [/fusion_text]more[one_third last=“no” spacing=“yes” background_color="" background_image="" background_repeat=“no-repeat” background_position=“left top” border_size=“0px” border_color="" border_style="" padding="" class="" id=""][title size=“2” content_align=“left” style_type=“single” sep_color="" class="" id=""]Temasek[/title][fusion_text]

Aranda Investments, Mauritius is a subsidiary of Temasek, a Government of Singapore investment arm.

[/fusion_text][fusion_text]

2.02 cr. shares

Rs. 1,915 cr.

[/fusion_text][/one_third][one_third last=“no” spacing=“yes” background_color="" background_image="" background_repeat=“no-repeat” background_position=“left top” border_size=“0px” border_color="" border_style="" padding="" class="" id=""][title size=“2” content_align=“left” style_type=“single” sep_color="" class="" id=""]Singapore Govt.[/title][fusion_text]

The Goverment of Singapore also invested directly in the issue, and brought in over Rs. 1,000 cr.

[/fusion_text][fusion_text]

1.26 cr. shares

Rs. 1,197 cr.

[/fusion_text][/one_third][one_third last=“yes” spacing=“yes” background_color="" background_image="" background_repeat=“no-repeat” background_position=“left top” border_size=“0px” border_color="" border_style="" padding="" class="" id=""][title size=“2” content_align=“left” style_type=“single” sep_color="" class="" id=""]Goldman Sachs[/title][fusion_text]

Goldman Sachs, Singapore also bought Daiichi’s holdings, with nearly 5,000 cr. invested in the issue.

[/fusion_text][fusion_text]

5.12 cr. shares

Rs. 4,864 cr.

[/fusion_text][/one_third][fusion_text]

Note: We assume investments were made at Rs. 950.

We will probably know of the others only if they bought more than 1% of the company or if they report these purchases elsewhere. All the trades were executed on the NSE, it seems.

[/fusion_text]